iSh Nasdaq Biot Shs  $276.55

up +2.43


29/8/2014 04:00 PM  |  NASDAQ : IBB
Get Trend Analysis Icon Get IBB Trend Analysis - it has outperformed the S&P 500 by 19%

Partner Headlines

  1. Isis Pharmaceuticals Finally Breaks Out

    Benzinga
  2. Yellen Says Social Media, Biotech Stocks 'Substantially Stretched'

    Benzinga
  3. 4 ETFs With Upside Potential

    Benzinga
  4. Dow Closes At A New High As Late-Month Rally Boosts Stocks

    Benzinga
  5. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  6. Stocks Revisit Session Lows; Share Offer Lifts GasLog

    IBD
  7. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  8. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  9. Biotech ETFs Come Back Down To Earth

    Benzinga
  10. ETF Outlook For Wednesday, March 26, 2014 (IBB, IPO, FPX, SOCL, FB, KING)

    Benzinga
  11. ETF Outlook For The Week Of March 24, 2014 (IBB, CARZ, RSX, GM)

    Benzinga
  12. Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough

    IBD
  13. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  14. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  15. ETF Outlook For The Week Of February 10 (IBB, VXZ, GREK, GDX)

    Benzinga
  16. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  17. ETF Outlook for Friday, December 20 (REM, USO, IBB, FCG)

    Benzinga
  18. The One True Sector Bubble: Profits Here When It Crashes Soon

    Benzinga
  19. ETF Outlook for Tuesday, November 26, 2013

    Benzinga
  20. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  21. Biotech Breakout Highlights Flawed ETF Thinking

    Benzinga
  22. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  23. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  24. Three ETFs That Have Blown Past Their 200-Day Lines

    Benzinga
  25. ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)

    Benzinga
  26. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  27. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  28. Use The Sharpe Ratio For Profits With These ETFs

    Benzinga
  29. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  30. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  31. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  32. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  33. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  34. S&P Likes a Trio of Biotech ETFs

    Benzinga
  35. ETFs to Watch October 23, 2012 (FCF, IBB, EWT)

    Benzinga
  36. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  37. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  38. When Cheaper Is Better With ETFs

    Benzinga
  39. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  40. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  41. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  42. ETFs to Watch July 3, 2012 (TNA, XLB, PCY)

    Benzinga
  43. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  44. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  45. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  46. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  47. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
  48. Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)

    Benzinga
  49. 10 ETFs That Should Lower Their Expense Ratios

    Benzinga
  50. Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, IBB, XBI)

    Benzinga
Trading Center